Clinical trial Recruiting at 1 site Interventional Ages 18 and up

How different doses of inspiratory muscle strength training affect blood pressure and blood vessel function

Official title: Dose-Response Effects of Inspiratory Muscle Strength Training on Blood Pressure and Vascular Function

Run by University of Minnesota · NCT07109739 · Data updated 2026-11-12

This 6-week test sees if different amounts of inspiratory muscle strength training lower systolic blood pressure and improve blood vessel function in adults with above-normal systolic blood pressure.

More Systolic Hypertension trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment144 (estimated)
SponsorUniversity of Minnesota
Academic / other
Locations1 site (Minneapolis, Minnesota)
StatusRecruiting
StartedOctober 24, 2025
Main results expectedMarch 31, 2027
Study endsMarch 31, 2027
Registry record updatedNovember 10, 2026
Trial IDNCT07109739 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 or older with resting systolic blood pressure ≥120 mmHg who are non-smokers, English-speaking, and have no serious cardiovascular or metabolic disease or contraindications to IMST.

Probably not a fit

People with established cardiovascular disease, recent abdominal surgery, ear conditions such as a ruptured eardrum, asthma with very low symptom perception, smokers, or those unable to attend in-person visits are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with resting systolic blood pressure of 120 mmHg or higher will complete 6 weeks of inspiratory muscle strength training (IMST) using the POWERbreathe K5 device at varying training doses. Resting systolic blood pressure and brachial artery flow-mediated dilation will be measured before and after the training period to examine dose-related responses. Participants must be at least 18 years old, non-smokers, English-speaking, and free of serious cardiovascular or metabolic disease and other contraindications to IMST. The protocol includes standardized pre-visit restrictions on food, caffeine, exercise, alcohol, and non-prescribed medications to ensure consistent measurement conditions.

Why it matters

Potential benefit: If successful, IMST could provide a non-drug way to lower systolic blood pressure and improve arterial health.

How similar studies have gone: Prior small clinical studies have shown that IMST can reduce blood pressure and improve vascular measures, but dose-response data over a 6-week period are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years
* Resting SBP ≥120 mmHg as measured during screening 1 \& 2
* Free from serious CV or metabolic diseases as identified by self-report and blood chemistry analysis.
* No contraindications to IMST (recent abdominal surgery, ruptured eardrum, asthma with very low symptom perception, fractured ribs, or pneumothorax)
* Language: English-speaking, with ability to comprehend study materials and instructions.
* Pre-visit Compliance: Willing to comply with pre-visit instructions (avoiding food and caffeine ≥ 3 hours, vigorous exercise, alcohol, and non-prescribed medications ≥ 24 hours) prior to each measurement visit.
* Lifestyle: Non-smokers (defined as self-report of not smoking cigarettes or vaping over the past year).

Exclusion Criteria:

* Self-report of history of cardiovascular disease, or conditions affecting the ear (e.g., ruptured eardrum).
* Recent abdominal surgery or presence of an abdominal hernia.
* Asthma with very low symptom perception, frequent severe exacerbations, or abnormally low perception of dyspnea.
* Ruptured eardrum or any other condition of the ear.
* Markedly elevated left ventricular end-diastolic volume and pressure.
* Current respiratory conditions such as a cold, sinusitis, or respiratory tract infection (participants may be included once they recover from the respiratory condition).
* Female-Specific: Pregnant or planning to become pregnant during the study period.
* Compliance: Unable or unwilling to comply with pre-visit restrictions (e.g., avoiding caffeine, alcohol, and exercise within specified hours before visits).

Where it's running

  • University of Minnesota
    Minneapolis, Minnesota, United States
    Recruiting

Study contacts

  • Principal investigator: Daniel Craighead, PhD — University of Minnesota
  • Study coordinator: Olivia Ruhland
  • Email: ruhla064@umn.edu
  • Phone: 612-624-1588

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.